Arvee Laboratories (India) Operational Benchmarking
₹211.15-2.65%
- Market cap
- ₹233 crore
- P/E
- 57.4
- P/B
- 6.89
- ROE
- 7.8%
- Dividend yield
- 1.20%
Arvee Laboratories (India) compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Arvee Laboratories (India) sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Arvee Laboratories (India) Limited | ₹211.15 | 57.4 | 233 | 1.2% | 4,500 | 7.8% |
| Median (1 Cos) | ₹211.15 | 57.4 | 233 | 1.2% | 4,500 | 7.8% |
Source: NSE sector index filings and financial statements. Data as of 7 October 2026. How this data is compiled.
Same Data For Peers
- Astec LifeSciences Limited operational benchmarking
- Artemis Medicare Services Limited operational benchmarking
- Aster DM Quality Care Limited operational benchmarking
- Apollo Hospitals Enterprise Limited operational benchmarking
- AstraZeneca Pharma India Limited operational benchmarking
- Alembic Pharmaceuticals Limited operational benchmarking
Trade Arvee Laboratories (India) With ATS
Track ARVEE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.